Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients

BACKGROUND: Gastric cancer relapse occurs in about 30% of the patients treated with gastrectomy and D2-lymphadenectomy, mainly as distant or peritoneal metastases. Hyperthermic intraperitoneal chemotherapy (HIPEC) has been associated with an improvement in survival and lower peritoneal recurrence, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Wilson L, Coimbra, Felipe J F, Ribeiro, Héber S C, Diniz, Alessandro L, de Godoy, André Luís, Begnami, MariaDirleiFS, Silva, Milton J B, Fanelli, Marcelo F, Mello, Celso A L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495866/
https://www.ncbi.nlm.nih.gov/pubmed/22992263
http://dx.doi.org/10.1186/1477-7819-10-195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495866/
https://www.ncbi.nlm.nih.gov/pubmed/22992263
http://dx.doi.org/10.1186/1477-7819-10-195

Ejemplares similares